Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Your are on :  Markets   |  News Analysis    |  Corporate Results   |Detailed News   
Back
Integrated Proteins standalone net profit declines 50.00% in the March 2024 quarter
27-Apr-24   07:27 Hrs IST

Net profit of Integrated Proteins declined 50.00% to Rs 0.02 crore in the quarter ended March 2024 as against Rs 0.04 crore during the previous quarter ended March 2023. Sales rose 41.18% to Rs 0.24 crore in the quarter ended March 2024 as against Rs 0.17 crore during the previous quarter ended March 2023.

For the full year,net profit rose 200.00% to Rs 0.09 crore in the year ended March 2024 as against Rs 0.03 crore during the previous year ended March 2023. Sales rose 41.18% to Rs 0.24 crore in the year ended March 2024 as against Rs 0.17 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
?Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales0.240.17 41 0.240.17 41
OPM %-20.830 --50.00-52.94 -
PBDT0.080.04 100 0.130.07 86
PBT0.080.05 60 0.100.04 150
NP0.020.04 -50 0.090.03 200

Powered by Capital Market - Live News

Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)